Clinical Trial

ATTR Cardiac Amyloidosis in a Selected Population

Recruiting
View on ClinicalTrials.gov →
Summary
Patients operated for carpal tunnel syndrome (CTS) at Ålesund Hospital (200 patients) will have a biopsy to diagnose ATTR amyloidosis. Patients with positive biopsy will be examined to decide wether they have cardiac amyloidosis. All patients with positive biopsy will be followed closely for 10 years wit echocardiography an clinically.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-06-10.
Status change: Not Yet Recruiting → Recruiting 2024-10-14
Trial Details
NCT Number NCT06458374
Lead Sponsor Helse Møre og Romsdal HF
Conditions ATTR Amyloidosis Wild Type, ATTR Gene Mutation, Carpal Tunnel Syndrome, Cardiac Amyloidosis
Enrollment 180 participants
Start Date 2024-09-01
Primary Completion 2034-02-28 (estimated)
Study Completion 2039-02-28 (estimated)
Updated on ClinicalTrials.gov 2026-08-12